Akari Therapeutics names Kameel Farag as interim CFO
Go back to Akari Therapeutics names Kameel Farag as interim CFO| (NASDAQ: AKTX) | Delayed: 7.90 +0.38 (5.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.52 | 52 Week High | $19.75 | |||
| Open | $7.30 | 52 Week Low | $7.63 | |||
| Day High | $8.00 | P/E | N/A | |||
| Day Low | $7.24 | EPS | $0.00 | |||
| Volume | 104,160 | |||||
